Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm
Authors
Keywords
Lung, Neuroendocrine, Tumours, Cluster analysis, Transition
Journal
VIRCHOWS ARCHIV
Volume 472, Issue 4, Pages 567-577
Publisher
Springer Nature
Online
2018-02-01
DOI
10.1007/s00428-018-2307-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Whole-genome landscape of pancreatic neuroendocrine tumours
- (2017) Aldo Scarpa et al. NATURE
- Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift
- (2017) Alessandra Fabbri et al. VIRCHOWS ARCHIV
- A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas
- (2016) Laura H. Tang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study
- (2016) Namrata Vijayvergia et al. BRITISH JOURNAL OF CANCER
- Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung
- (2016) Tomohiro Miyoshi et al. CLINICAL CANCER RESEARCH
- Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets
- (2016) N. Rekhtman et al. CLINICAL CANCER RESEARCH
- Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms
- (2016) Stefano La Rosa et al. ENDOCRINE PATHOLOGY
- Pathologic Classification of Neuroendocrine Neoplasms
- (2016) David S. Klimstra HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Thermodynamic measures of cancer: Gibbs free energy and entropy of protein–protein interactions
- (2016) Edward A. Rietman et al. JOURNAL OF BIOLOGICAL PHYSICS
- Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role forTERT,RB1,MEN1andKMT2D
- (2016) Michele Simbolo et al. JOURNAL OF PATHOLOGY
- Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer
- (2016) Nicola Fusco et al. MODERN PATHOLOGY
- Glioblastoma: pathology, molecular mechanisms and markers
- (2015) Kenneth Aldape et al. ACTA NEUROPATHOLOGICA
- Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group
- (2015) Claudia Vollbrecht et al. BRITISH JOURNAL OF CANCER
- Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas
- (2015) L. H. Tang et al. CLINICAL CANCER RESEARCH
- NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas
- (2015) Lydia Meder et al. INTERNATIONAL JOURNAL OF CANCER
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Definition of Primary and Secondary Glioblastoma--Response
- (2014) H. Ohgaki et al. CLINICAL CANCER RESEARCH
- Tumor genetics and survival of thymic neuroendocrine neoplasms: A multi-institutional clinicopathologic study
- (2014) Philipp Ströbel et al. GENES CHROMOSOMES & CANCER
- Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids
- (2014) Lynnette Fernandez-Cuesta et al. Nature Communications
- An exploration of pathways involved in lung carcinoid progression using gene expression profiling
- (2013) Dorian R.A. Swarts et al. CARCINOGENESIS
- CD44 and OTP Are Strong Prognostic Markers for Pulmonary Carcinoids
- (2013) D. R. A. Swarts et al. CLINICAL CANCER RESEARCH
- MEN1Gene Mutation and Reduced Expression Are Associated With Poor Prognosis in Pulmonary Carcinoids
- (2013) Dorian R. A. Swarts et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Neuroendocrine tumours—challenges in the diagnosis and classification of pulmonary neuroendocrine tumours
- (2013) M A den Bakker et al. JOURNAL OF CLINICAL PATHOLOGY
- Gastroenteropancreatic neuroendocrine neoplasms: Historical context and current issues
- (2013) Zhaohai Yang et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- Molecular and cellular biology of neuroendocrine lung tumors: Evidence for separate biological entities
- (2012) Dorian R.A. Swarts et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
- (2012) Martin Peifer et al. NATURE GENETICS
- Deletions of 11q22.3-q25 Are Associated with Atypical Lung Carcinoids and Poor Clinical Outcome
- (2011) Dorian R.A. Swarts et al. AMERICAN JOURNAL OF PATHOLOGY
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
- (2011) L. V. Sequist et al. Science Translational Medicine
- Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability
- (2010) Michael A den Bakker et al. HISTOPATHOLOGY
- Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors
- (2010) J. Voortman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases
- (2009) L. Righi et al. ANNALS OF ONCOLOGY
- A small-cell lung cancer genome with complex signatures of tobacco exposure
- (2009) Erin D. Pleasance et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started